Laboratory Developed Test Market Dominant In North America With Largest Market Share
Laboratory Developed Test Market Insights:
In a recent research report by Market
Research Community, the Laboratory Developed Test Market is expected to surpass
USD 7.77 Billion by the year 2028, from USD 4.87 Billion in 2021.
The Laboratory
Developed Test Market Share is projected to grow at a significant pace
reaching a CAGR of approximately 6.9%, over the forecast period of 2022–2030,
despite a considerable fall in product sales during the initial phase of the
pandemic spread and lockdown restrictions imposed globally.
A laboratory
developed test (LDT) is a diagnostic test that is designed, manufactured, and
used within a single laboratory. These tests are not required to go through the
same premarket clearance or approval process as tests that are commercially
available, also known as "cleared" or "approved" tests.
Laboratory
Developed Tests are often used to detect rare or newly discovered diseases, or
to monitor the effectiveness of treatment. They may also be used to detect
genetic mutations, to confirm the presence of a disease or to monitor its
progression. Laboratory Developed Tests are typically validated by the
laboratory that develops them and are subject to quality control and quality
assurance procedures.
Get sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=558
The study is
consolidated into major segments and further into sub-segments, such as By Type
(Molecular Diagnostics, Clinical Biochemistry, Critical Care, Immunology,
Microbiology, Haematology, Others), By Application (Specialty Diagnostic
Centers, Clinical Research organizations, Hospitals laboratory, Academic
Institutes, Others), to forecast the market size by value.
By Type
·
Molecular
Diagnostics
·
Clinical
Biochemistry
·
Critical
Care
·
Immunology
·
Microbiology
·
Haematology
·
Others
By Application
·
Specialty
Diagnostic Centers
·
Clinical
Research organizations
·
Hospitals
laboratory
·
Academic
Institutes
·
Others
Laboratory Developed Test Market Includes
Key Players:
·
Hoffmann-La
Roche Ltd
·
Quest
Diagnostics Incorporated
·
QIAGEN
·
Illumina,
Inc.
·
Adaptive
Biotechnologies
·
Biotheranostics
·
Rosetta
Genomics Ltd.,
·
Guardant
Health
·
Eurofins
Scientific
·
Biodesix
Laboratory
Developed Test Market Growth, and Asian nations are steadily emerging as a
result of government policies that are favorable to this market and growing
public understanding of the advantages of these systems. Further, regions such
as the Latin America, and Europe Middle East and Africa, are expected to boost
the market expansion during the forecast period.
By Region
•
Europe- (France, U.K., Russia, Italy, Spain,
Germany, BENELUX, Rest of Europe)
•
Asia Pacific- (South Korea, Australia, China,
Japan, India, ASEAN, Rest of Asia Pacific)
•
North America– (U.S., Canada, Mexico)
•
Latin America- (Chile, Brazil, Argentina, Rest of
Latin America)
•
Middle East and Africa- (Turkey, Israel, GCC, Rest of MEA)
Market Research Community
Email: sales@marketresearchcommunity.com
Contact no.: (US) +1-214-272-0393
(UK) +44-20-8133-9198
Comments
Post a Comment